HRP20110814T1 - Metoda konzerviranja čestica virusa - Google Patents
Metoda konzerviranja čestica virusa Download PDFInfo
- Publication number
- HRP20110814T1 HRP20110814T1 HR20110814T HRP20110814T HRP20110814T1 HR P20110814 T1 HRP20110814 T1 HR P20110814T1 HR 20110814 T HR20110814 T HR 20110814T HR P20110814 T HRP20110814 T HR P20110814T HR P20110814 T1 HRP20110814 T1 HR P20110814T1
- Authority
- HR
- Croatia
- Prior art keywords
- concentration
- sugar
- virus
- polyethyleneimine
- solution
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 14
- 239000002245 particle Substances 0.000 title claims abstract 14
- 230000003612 virological effect Effects 0.000 title 1
- 241000700605 Viruses Species 0.000 claims abstract 18
- 235000000346 sugar Nutrition 0.000 claims abstract 18
- 229920002873 Polyethylenimine Polymers 0.000 claims abstract 10
- 239000000243 solution Substances 0.000 claims abstract 8
- 150000008163 sugars Chemical class 0.000 claims abstract 5
- 239000007864 aqueous solution Substances 0.000 claims abstract 3
- 239000011159 matrix material Substances 0.000 claims abstract 3
- 239000007787 solid Substances 0.000 claims abstract 3
- 239000000126 substance Substances 0.000 claims 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 3
- 229930006000 Sucrose Natural products 0.000 claims 3
- 238000004321 preservation Methods 0.000 claims 3
- 239000005720 sucrose Substances 0.000 claims 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims 2
- 238000001035 drying Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 229940031348 multivalent vaccine Drugs 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 150000005846 sugar alcohols Chemical class 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32151—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Jellies, Jams, And Syrups (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0705245.9A GB0705245D0 (en) | 2007-03-19 | 2007-03-19 | Stable biological products |
| US91722007P | 2007-05-10 | 2007-05-10 | |
| PCT/GB2008/000987 WO2008114021A1 (en) | 2007-03-19 | 2008-03-19 | Method for preserving viral particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110814T1 true HRP20110814T1 (hr) | 2012-01-31 |
Family
ID=38008686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110814T HRP20110814T1 (hr) | 2007-03-19 | 2011-11-02 | Metoda konzerviranja čestica virusa |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8313897B2 (ko) |
| EP (1) | EP2121898B8 (ko) |
| JP (1) | JP2010521961A (ko) |
| KR (1) | KR20100015613A (ko) |
| CN (1) | CN101636486A (ko) |
| AT (1) | ATE525455T1 (ko) |
| AU (1) | AU2008228086A1 (ko) |
| BR (1) | BRPI0808960A2 (ko) |
| CA (1) | CA2681182A1 (ko) |
| DK (1) | DK2121898T3 (ko) |
| ES (1) | ES2370675T3 (ko) |
| GB (2) | GB0705245D0 (ko) |
| HR (1) | HRP20110814T1 (ko) |
| IL (1) | IL200671A0 (ko) |
| PL (1) | PL2121898T3 (ko) |
| RU (1) | RU2009138344A (ko) |
| SI (1) | SI2121898T1 (ko) |
| WO (1) | WO2008114021A1 (ko) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5214464B2 (ja) | 2005-12-28 | 2013-06-19 | アドバンスド バイオニュートリション コーポレーション | 多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法 |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| WO2008076975A1 (en) | 2006-12-18 | 2008-06-26 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
| AU2009295623A1 (en) | 2008-09-24 | 2010-04-01 | Stabilitech Ltd | Method for preserving polypeptides using a sugar and polyethyleneimine |
| CA2986751A1 (en) | 2009-03-27 | 2010-09-30 | Intervet International B.V. | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| JP5804453B2 (ja) * | 2009-05-14 | 2015-11-04 | 国立大学法人 東京大学 | 結晶性ポリオール微粒子及びその調製方法 |
| JP5841527B2 (ja) | 2009-05-26 | 2016-01-13 | アドバンスド バイオニュートリション コーポレーション | 生物学的に活性な微生物および／または生物活性材料を含む安定な乾燥粉末組成物およびその製造方法 |
| CN102725393B (zh) * | 2010-01-28 | 2015-12-02 | 先进生物营养公司 | 包含生物活性材料的干燥玻璃质组合物 |
| US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
| GB201002419D0 (en) * | 2010-02-12 | 2010-03-31 | Isis Innovation | Stable live vaccine formulations |
| JP5960120B2 (ja) | 2010-03-31 | 2016-08-02 | スタビリテック リミテッド | ウイルス粒子の安定化 |
| GB2499480A (en) | 2010-03-31 | 2013-08-21 | Stabilitech Ltd | Method for preserving alum adjuvants and alum-adjuvanted vaccines |
| EP2552478B1 (en) * | 2010-03-31 | 2016-12-21 | Stabilitech Ltd. | Excipients for stabilising viral particles |
| SG187250A1 (en) | 2010-08-13 | 2013-03-28 | Advanced Bionutrition Corp | Dry storage stabilizing composition for biological materials |
| AU2011336410B2 (en) | 2010-12-02 | 2015-01-22 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
| WO2012075379A2 (en) | 2010-12-02 | 2012-06-07 | Oncolytics Biotech Inc. | Liquid viral formulations |
| GB201117233D0 (en) | 2011-10-05 | 2011-11-16 | Stabilitech Ltd | Stabilisation of polypeptides |
| TWI690322B (zh) | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
| GB201406569D0 (en) | 2014-04-11 | 2014-05-28 | Stabilitech Ltd | Vaccine compositions |
| US10555981B2 (en) | 2014-07-16 | 2020-02-11 | Transgene S.A. | Oncolytic virus for expression of immune checkpoint modulators |
| WO2016131945A1 (en) | 2015-02-20 | 2016-08-25 | Transgene Sa | Combination product with autophagy modulator |
| DK3328215T3 (da) | 2015-07-29 | 2021-09-13 | Advanced Bionutrition Corp | Stabilt tørre probiotiske sammensætninger til særlige kostanvendelser |
| US10752876B2 (en) | 2015-09-02 | 2020-08-25 | Mcmaster University | Enhanced thermal stability for adenoviral vectors through spray drying |
| US20190134190A1 (en) | 2016-05-04 | 2019-05-09 | Transgene Sa | Combination therapy with cpg tlr9 ligand |
| TW201825674A (zh) | 2016-09-09 | 2018-07-16 | 美商艾斯合顧問有限公司 | 表現雙特異性接合分子的溶瘤病毒 |
| EP3522920A2 (en) | 2016-10-10 | 2019-08-14 | Transgene SA | Immunotherapeutic product and mdsc modulator combination therapy |
| WO2018091680A1 (en) | 2016-11-18 | 2018-05-24 | Transgene Sa | Cowpox-based oncolytic vectors |
| US11626228B2 (en) * | 2016-12-22 | 2023-04-11 | Rogers Corporation | Multi-layer magneto-dielectric material |
| CN110168092A (zh) | 2016-12-28 | 2019-08-23 | 特朗斯吉有限公司 | 溶瘤病毒和治疗分子 |
| US10617756B2 (en) | 2017-01-05 | 2020-04-14 | Shimojani, LLC | Drug regimen for treatment of cerebral ischemia |
| GB2562241B (en) | 2017-05-08 | 2022-04-06 | Stabilitech Biopharma Ltd | Vaccine compositions |
| CN111065406A (zh) | 2017-06-21 | 2020-04-24 | 特兰斯吉恩股份有限公司 | 个性化疫苗 |
| WO2019020543A1 (en) | 2017-07-28 | 2019-01-31 | Transgene Sa | ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS |
| JP2021516957A (ja) | 2018-03-07 | 2021-07-15 | トランジェーヌＴｒａｎｓｇｅｎｅ | パラポックスウイルスベクター |
| WO2020011754A1 (en) | 2018-07-09 | 2020-01-16 | Transgene | Chimeric vaccinia viruses |
| AU2019345595A1 (en) * | 2018-09-28 | 2021-04-15 | Otsuka Pharmaceutical Factory,Inc. | Mammal cell preserving solution containing acarbose or stachyose |
| US20210386807A1 (en) | 2018-10-30 | 2021-12-16 | The University Of Tokyo | Oncolytic virus for cancer therapy |
| MX2021007860A (es) | 2018-12-28 | 2021-10-26 | Transgene | Poxvirux deficiente en m2. |
| WO2020136232A1 (en) | 2018-12-28 | 2020-07-02 | Transgene Sa | Immunosuppressive m2 protein |
| WO2021211740A1 (en) * | 2020-04-14 | 2021-10-21 | Spectrum Solutions L.L.C. | Products and methods for detection of viral nucleic acid |
| EP4178605A1 (en) | 2020-07-13 | 2023-05-17 | Transgene | Treatment of immune depression |
| EP4303233A1 (en) | 2021-02-01 | 2024-01-10 | St Phi Therapeutics Co., Ltd. | Targeted protein degradation system and use thereof |
| JP2024519800A (ja) * | 2021-05-21 | 2024-05-21 | タケダ ワクチン，インコーポレイテッド | 固体組成物、フリーズドライ方法およびガラスバイアル |
| CN113655057A (zh) * | 2021-08-24 | 2021-11-16 | 威世药业（如皋）有限公司 | 一种检测冷冻干燥处理对痘苗病毒毒力影响的设备 |
| WO2023025899A2 (en) | 2021-08-26 | 2023-03-02 | Transgene | Delivery system for targeting genes of the interferon pathway |
| CN114392237B (zh) * | 2021-12-28 | 2024-02-02 | 上海允英生物医药科技有限公司 | 一种冻干病毒制剂及其制备方法 |
| WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
| WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
| WO2024003353A1 (en) | 2022-07-01 | 2024-01-04 | Transgene | Fusion protein comprising a surfactant-protein-d and a member of the tnfsf |
| WO2024038175A1 (en) | 2022-08-18 | 2024-02-22 | Transgene | Chimeric poxviruses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999027071A1 (en) * | 1997-11-26 | 1999-06-03 | Universal Preservation Technologies, Inc. | Preservation of sensitive biological samples by vitrification |
| EP1253932B1 (en) | 2000-02-08 | 2005-04-27 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions |
| US20040110267A1 (en) * | 2000-12-15 | 2004-06-10 | Stratagene | Room temperature stable competent cells |
| GB0502661D0 (en) * | 2005-02-09 | 2005-03-16 | Stabilitech Ltd | A desiccated product |
| KR20110126726A (ko) * | 2005-10-07 | 2011-11-23 | 화이자 프로덕츠 인코포레이티드 | 개과 동물의 인플루엔자의 치료를 위한 백신 및 방법 |
-
2007
- 2007-03-19 GB GBGB0705245.9A patent/GB0705245D0/en not_active Ceased
-
2008
- 2008-03-19 SI SI200830486T patent/SI2121898T1/sl unknown
- 2008-03-19 KR KR1020097021553A patent/KR20100015613A/ko not_active Application Discontinuation
- 2008-03-19 CA CA002681182A patent/CA2681182A1/en not_active Abandoned
- 2008-03-19 RU RU2009138344/10A patent/RU2009138344A/ru not_active Application Discontinuation
- 2008-03-19 AU AU2008228086A patent/AU2008228086A1/en not_active Abandoned
- 2008-03-19 DK DK08718824.9T patent/DK2121898T3/da active
- 2008-03-19 GB GB0915291A patent/GB2459611B/en not_active Expired - Fee Related
- 2008-03-19 CN CN200880008926A patent/CN101636486A/zh active Pending
- 2008-03-19 EP EP08718824A patent/EP2121898B8/en not_active Not-in-force
- 2008-03-19 WO PCT/GB2008/000987 patent/WO2008114021A1/en active Application Filing
- 2008-03-19 ES ES08718824T patent/ES2370675T3/es active Active
- 2008-03-19 BR BRPI0808960-4A patent/BRPI0808960A2/pt not_active IP Right Cessation
- 2008-03-19 AT AT08718824T patent/ATE525455T1/de active
- 2008-03-19 PL PL08718824T patent/PL2121898T3/pl unknown
- 2008-03-19 JP JP2009554082A patent/JP2010521961A/ja not_active Withdrawn
- 2008-03-19 US US12/531,902 patent/US8313897B2/en not_active Expired - Fee Related
-
2009
- 2009-09-01 IL IL200671A patent/IL200671A0/en unknown
-
2011
- 2011-11-02 HR HR20110814T patent/HRP20110814T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2459611B (en) | 2011-02-16 |
| AU2008228086A1 (en) | 2008-09-25 |
| IL200671A0 (en) | 2011-08-01 |
| EP2121898B1 (en) | 2011-09-21 |
| RU2009138344A (ru) | 2011-04-27 |
| US20100015177A1 (en) | 2010-01-21 |
| ATE525455T1 (de) | 2011-10-15 |
| GB2459611A (en) | 2009-11-04 |
| CN101636486A (zh) | 2010-01-27 |
| BRPI0808960A2 (pt) | 2014-08-26 |
| CA2681182A1 (en) | 2008-09-25 |
| ES2370675T3 (es) | 2011-12-21 |
| JP2010521961A (ja) | 2010-07-01 |
| US8313897B2 (en) | 2012-11-20 |
| GB0915291D0 (en) | 2009-10-07 |
| EP2121898B8 (en) | 2012-02-15 |
| SI2121898T1 (sl) | 2012-02-29 |
| WO2008114021A1 (en) | 2008-09-25 |
| DK2121898T3 (da) | 2012-01-09 |
| EP2121898A1 (en) | 2009-11-25 |
| GB0705245D0 (en) | 2007-04-25 |
| PL2121898T3 (pl) | 2012-02-29 |
| KR20100015613A (ko) | 2010-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110814T1 (hr) | Metoda konzerviranja čestica virusa | |
| JP2010521961A5 (ko) | ||
| NZ601017A (en) | Dry glassy composition comprising a bioactive material | |
| JP2016535065A5 (ko) | ||
| MX350047B (es) | Composicion de estabilizacion de almacenamiento en seco para materiales biologicos. | |
| MY178686A (en) | Stabilizing composition for biological materials | |
| NZ726315A (en) | Methods for freeze-drying and rehydrating biologics | |
| RU2011120425A (ru) | Смесь для консервации и ее применение | |
| HRP20220035T1 (hr) | Otopine za povećanje učinkovitosti propikonazola na živim biljkama i srodne metode | |
| WO2016119052A8 (en) | Compositions and methods for enhancing oncolytic virus efficacy | |
| MX349837B (es) | Composicion de transglutaminasa seca. | |
| CN104743555B (zh) | 一种高着火点颗粒活性炭制备方法 | |
| WO2017180344A4 (en) | Viral vector stabilization | |
| CN102626520A (zh) | 一种水貂犬瘟热活疫苗耐热冻干保护剂及制备方法 | |
| CN105325407A (zh) | 一种含腐植酸表面活性剂 | |
| MD20160090A2 (ro) | Compoziţie cu conţinut de oxid de fier (III) pentru stabilizarea solului | |
| CN103893776A (zh) | 羊传染性脓疱病毒细胞弱毒疫苗耐热冻干保护剂及其制备方法和应用 | |
| EP3615006A1 (en) | Antigenic thermostable polio vaccines&related methods | |
| CN105777313A (zh) | 一种肥料增效剂 | |
| UA139619U (uk) | Спосіб захисту техніки та обладнання від радіоактивного забруднення | |
| Lang et al. | The fusiform green alga Desmatractum spryii (Chlorophyta, Chlorococcales): a noteworthy discovery made in a peninsula loch, SW Scotland | |
| CN103783333A (zh) | 一种去除干蘑菇中残留农药的方法 | |
| Jeong et al. | Comparison and Verification of Static and Dynamic Flux Chamber Method for the Measurement of Methane Surface Emissions | |
| Garcez et al. | Physical properties of cement-wood composites with treated Pinus elliottii sawdust. | |
| CN105950599A (zh) | 猪链球菌噬菌体裂解酶的冻干保护剂 |